-
Global First, with China’s Participation! Drs. Wenyu Yang & Wenbin An Discuss the Development, Highlights, and Clinical Relevance of the First International Expert Consensus on Pediatric Chronic Phase CML
The recently published “Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations” in the prestigious journal Leukemia marks a historic milestone as the first international expert consensus focused on chronic-phase chronic myeloid leukemia (CML) in children and adolescents.
-
From Pioneering Efforts to Global Leadership – Academician Xiaojun Huang Charts China’s Transformative Journey
From April 11 to 12, 2025, the Hematology Branch of the China International Exchange and Promotive Association for Medical and Health Care(CPAM) held its annual academic meeting in Qingdao, Shandong Province, alongside the “Hua Tuo Project” MDT Forum. During the event, Academician Xiaojun Huang—Conference Chair, Director of the Hematology Branch of the CPAM , and…
-
CSCO BC | “Best of SGBCC” Resonates at the National Breast Cancer Conference: Bridging Borders, Advancing Science
On April 12, 2025, the “Best of St. Gallen 2025” session, co-hosted by the Breast Cancer Committee of the Chinese Society of Clinical Oncology (CSCO BC) and the St. Gallen International Breast Cancer Conference (SGBCC), was successfully held during the National Breast Cancer Conference in China.
-
Writing China’s Own Guidelines: Professor Zefei Jiang on the Evolution and Global Vision of the CSCO Breast Cancer Guidelines
As one of the five initial professional guideline projects launched by the Chinese Society of Clinical Oncology (CSCO) in 2016, the CSCO Breast Cancer Guidelines (CSCO BC Guidelines) have become a cornerstone of breast cancer care in China. Since the publication of the first edition in 2017, the guidelines have undergone yearly updates, evolving in…
-
Professor Zhengqiang Yang Offers In-Depth Interpretation of the 2024 Edition of the Primary Liver Cancer Guidelines: Updates in Interventional and Local Therapies
Since the release of the 2022 edition of the Primary Liver Cancer Diagnosis and Treatment Guidelines, numerous high-quality studies—both domestic and international—have advanced the field of hepatocellular carcinoma (HCC), especially in diagnosis, staging, and treatment. Research reflecting China’s real-world clinical settings has provided important theoretical guidance for the management of liver cancer. Building on accumulated…
-
Professor Zhengqiang Yang on 2024 Liver Cancer Guidelines: Advances in Interventional and Local Therapies
To provide professional insights into the latest revisions concerning interventional and local therapies, Oncology Frontier invited Professor Zhengqiang Yang from the Cancer Hospital Chinese Academy of Medical Sciences to share…
-
CSCO BC Guidelines | Unlocking a New Chapter in Anti-HER2 Therapy — Professor Jianbin Li Interprets Key Updates to the 2025 CSCO BC Guidelines
Oncology Frontier: The 2025 edition of the CSCO BC Guidelines was officially released at this year’s National Breast Cancer Conference. Could you share some of the key updates clinicians should…
-
Cancer Patients Rehabilitation Rally is Underway!
On April 20, 2025, the “Beyond Limits” Cancer Patients Rehabilitation Rally was officially launched across China. Organized by the Cancer Rehabilitation Society of CACA , and supported by Hengrui Pharmaceuticals, the initiative harnesses digitization and other cutting-edge technologies to enhance long-term survival rates and quality of life for cancer patients.
Connecting Medical Expertise through Media